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Abstract
Morphine has been reported to accelerate the progression of chronic kidney disease. However, whether morphine affects
slit diaphragm (SD), the major constituent of glomerular filtration barrier, is still unclear. In the present study, we examined
the effect of morphine on glomerular filtration barrier in general and podocyte integrity in particular. Mice were
administered either normal saline or morphine for 72 h, then urine samples were collected and kidneys were subsequently
isolated for immunohistochemical studies and Western blot. For in vitro studies, human podocytes were treated with
morphine and then probed for the molecular markers of slit diaphragm. Morphine-receiving mice displayed a significant
increase in albuminuria and showed effacement of podocyte foot processes. In both in vivo and in vitro studies, the
expression of synaptopodin, a molecular marker for podocyte integrity, and the slit diaphragm constituting molecules
(SDCM), such as nephrin, podocin, and CD2-associated protein (CD2AP), were decreased in morphine-treated podocytes. In
vitro studies indicated that morphine modulated podocyte expression of SDCM through opiate mu (MOR) and kappa (KOR)
receptors. Since morphine also enhanced podocyte oxidative stress, the latter seems to contribute to decreased SDCM
expression. In addition, AKT, p38, and JNK pathways were involved in morphine-induced down regulation of SDCM in
human podocytes. These findings demonstrate that morphine has the potential to alter the glomerular filtration barrier by
compromising the integrity of podocytes.
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Introduction
Morphine, a metabolite of heroin, is the main stay of pain
management after surgery, angina, myocardial infarction, and
trauma [1]. However, heroin has also been one of the main drugs
abused for addiction, and has significantly contributed to
morbidity and mortality since the early 1990s in the United States
[2,3,4,5].
Morphine has been reported to exert a bimodal effect on the
growth of kidney fibroblasts and glomerular mesangial cells
[6,7,8,9,10]. Intravenous opiate addiction has also been consid-
ered a risk factor for the development of human immunodeficien-
cy (HIV)-associated nephropathy [11,12]. Johnson et al reported
that morphine administration altered the microprojections on
podocytes [13]. We also reported earlier that morphine promoted
glomerular epithelial cell proliferation at lower concentration
while triggered apoptosis at higher concentration [8]. We
demonstrated that morphine-induced alteration in epithelial cell
phenoytype was mediated by alteration of hemoxygenase (HO)-1
activity; however, in these studies, we did not study any loss of
visceral epithelial cell (podocyte) markers in response to morphine
[8]. Thus, the present study not only provides data on the effect of
morphine on glomerular visceral epithelial cells (podocytes) in vivo,
but also examines the effect of morphine on the markers of visceral
epithelial cell integrity.
As the major constituent of glomerular filtration barrier (GFB),
slit diaphragm (SD) plays an important role in the prevention of
glomerular protein leakage both in physiological and in patholog-
ical states. SD consists of proteins specifically expressed by
podocytes, such as nephrin, podocin, CD2-associated protein
(CD2AP), and synaptopodin [14]. On that account, the podocyte
is considered the key cell contributing to the development of
albuminuric kidney diseases. Decrease of nephrin and podocin has
been shown to be linked with albuminuria and progressive renal
disease [15,16]. Whether morphine impairs the SD constituting
molecules (SDCM) has yet to be studied.
In the present study, we evaluated the effect of morphine on
glomerular filtration barrier in general and podocyte integrity in
particular. We showed that morphine-receiving mice not only
developed albuminuria but also displayed attenuated expression of
SDCM in human podocytes. We also demonstrated that
morphine-induced loss of podocyte integrity through loss of slit
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diaphragm associated molecules is mediated by reactive oxygen
species (ROS) generation. These findings provide a basis to
support the hypothesis that morphine-induced direct impairment
of podocytes contributes to kidney disease.
Materials and Methods
Reagents
Morphine pellets were obtained from National Institute on
Drug Abuse (Bethesda, MD, USA). For in vitro study, morphine
was dissolved in normal saline, stored at a concentration of
1021 M, and used in concentrations of 10210 to 1026 M. [D-
Pen2,5]-Enkephalin (DPDPE), [D-Ala2, N-Me-Phe4, Gly5-ol]-
Enkephalin (DAMGO), 2-(3,4-Dichlorophenyl)-N-methyl-N-
[(1S)-1-(2-isopropyl)-2-(1-(3-pyrrolinyl))ethyl] acetamide hydro-
chloride (LPK26) were obtained from Sigma Aldrich (St. Louis,
MO). LY294002, SP600125, and SB203580 were purchased from
Cell Signaling Technology (Danvers, MA).
Animal experiments
All animal experiments complied with Institutional Animal
Care and Use Committee (IACUC)-approved protocols. FVB/N
mice (purchased from Jackson Laboratory, eight in each group)
were administered either normal saline or morphine (by subcu-
taneous implantation of a 75-mg slow-release morphine pellet).
After 72 h, spot urine samples were collected by giving gentle
pressure over the urinary bladder. The mice were subsequently
sacrificed and the kidneys were isolated for renal immunohisto-
chemical and Western blotting studies. Albumin and creatinine in
the urine were measured with Albuwell M Test Kit (Cat# 1011,
Exocell, Philadelphia, PA) and Creatinine Companion (Cat#
1012, Exocell), respectively, following the instruction of the
manufacturer.
Culture of human podocytes
Human podocytes were cultured as previously reported [17].
Briefly, immortalized human podocytes proliferated in the
growth medium containing RPMI 1640 supplemented with
10% fetal bovine serum, 1 X pecicillin-streptomycin, 1 mM L-
glutamine, and 1 X insulin, transferrin, and selenium (ITS)
(Invitrogen, Grand Island, NY) at permissive temperature (33uC).
When the cells reached about 80% confluence, they were
transferred to 37uC for differentiation in a medium without ITS
for 7 days.
RT-PCR
Total RNA was isolated from human podocytes using Trizol
reagent (Invitrogen). Five micrograms of total RNA were reverse
transcribed using the first-strand synthesis system (Invitrogen).
PCR was performed by using Platinum PCR SuperMix High
Fidelity (Invitrogen). Sequences of primers for human opiate




(KOR-RV), GATCATGGCCCTCTACTCCA (MOR-FW), and
GCATTTCGGGGAGTACGGAA (MOR-RV). GAPDH was
used as internal control, and the primers were GGGAAGCT-
CACTGGCATGGCCTTCC (GAPDH-FW) and
CATGTGGGCCATGAGGTCCACCAC (GAPDH-RV). Ampli-
fication was performed at 95uC for 5 min, followed by 30 cycles at
94uC for 1 min, 55uC for 30 s, 68uC for 1 min with a final
extension cycle for 5 min at 68uC. DNA samples were visualized
by 2% agarose gel electrophoresis.
Immunofluorescent microscopy
Immunofluorescent microscopy was performed as previously
reported [18]. Briefly, the kidneys were perfused in situ and then
fixed with fresh 4% PFA and stored at 280uC. Subsequently,
paraffin sections (4 mm) were prepared and de-paraffinized in
xylene and re-hydrated through graded concentrations of alcohol.
Epitope retrieval was carried out by heating the samples at 98uC
for 2 h in Retrieveall-1 (Signet Laboratories, Inc.). Subsequently,
cooled samples were permeabilized with 0.3% triton X-100 for
10 min, and were blocked with 2% BSA in 0.1% triton X-100 for
1 h at room temperature. Sections were then incubated with
primary antibodies overnight at 4uC, followed by Alexa Fluor
secondary antibodies (Invitrogen, 1:800), donkey anti-rabbit IgG
Alexa Fluor 488, donkey anti-goat lgG Alexa Fluor 594, goat anti-
mouse IgG Alexa Fluo 488, or goat anti-rabbit IgG Alexa Fluo
568, for 1 hour at room temperature. Primary antibodies included
rabbit anti-Mu/Kappa/Delta opiate receptors (Abcam, 1:200),
rabbit anti-synaptopodin (Santa Cruz, 1:100), mouse anti-8-
OHdG (Santa Cruz, 1:100), and goat anti-nephrin (R&D systems,
1:50). All antibodies were diluted in 0.1% Triton X-100, 2% BSA
in PBS. Cells were then counterstained with DAPI to identify
nuclei (Sigma-Aldrich). Morphological changes were visualized
and captured with a ZEISS microscope (Carl Zeiss MicoImaging
GmbH, Jena, Germany) equipped with a digital imaging system.
Western blot analysis
Cells were rinsed twice with PBS and lysed by M-PER Protein
Extraction Buffer (Pierce, Rockford, IL) containing 16 protease
inhibitor cocktail (Roche Diagnostics, Indianapolis, IN). Proteins
(20–30 mg) were separated by 10% SDS-polyacrylamide gel
electrophoresis (PAGE) and then transferred to an Immuno-Blot
polyvinylidene fluoride (PVDF) membrane (Bio-Rad, Hercules,
CA). After blocking in PBS/Tween (0.1%) with 5% nonfat milk,
the membrane was incubated with primary antibodies overnight at
4uC followed by horseradish peroxidase-conjugated secondary
antibodies (Santa Cruz, 1:3000) and then developed using
Enhanced Chemiluminescent (ECL) solution (Pierce). Primary
antibodies included rabbit anti-nephrin (Santa Cruz, 1:1000), goat
anti-synaptopodin (Santa Cruz, 1:1000), mouse anti-CD2AP
(Santa Cruz, 1:1000), rabbit anti-podocin (Sigma, 1:200), goat
anti-actin (Santa Cruz, 1:1000), rabbit anti-phospho-JNK (Cell
Figure 1. Opiate receptors are expressed in human podocytes.
Total RNAs were prepared from human podocytes (labeled as P1, P2),
and were used for RT-PCR to detect the expression of delta opiate
receptor (DOR), kappa opiate receptor (KOR), and mu opiate receptor
(MOR). RNAs from human fetal brain (B) were used as positive control.
GAPDH was used as internal control.
doi:10.1371/journal.pone.0055748.g001
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Signaling, 1:1000), rabbit anti-JNK (Cell Signaling, 1:1000), rabbit
anti-phospho-Akt (Cell Signaling, 1:1000), rabbit anti-Akt (Cell
Signaling, 1:1000), rabbit anti-phospho-p38 (Cell Signaling,
1:1000), and rabbit anti-p38 (Cell Signaling, 1:1000). For data
quantification, the films were scanned with a CanonScan 9950F
scanner and the acquired images were then analyzed using the
public domain NIH image program (developed at the U.S.
National Institutes of Health and available on the internet at
http://rsb.info.nih.gov/nih-image/).
Intracellular ROS measurement
Human podocytes were differentiated in 96-well plates for
7 days as mentioned above, and were then cultured in serum free
medium for 12 h. Subsequently, 10210 to 1026 M morphine was
added. After incubation for another 12 h, intracellular ROS was
determined by analyzing the fluorescence intensity of the
intracellular fluoroprobe 2, 7-dichlorofluorescin (DCFH) (Molec-
ular probe, Carlsbad, CA, USA), following the manufacturer’s
instructions.
Electron Microscopic (EM) studies
Mice in groups of five were administered either normal saline or
morphine. Kidneys were harvested and fixed in glutaraldehyde
and embedded in EPON. Thin sections were cut and reviewed
and examined under a transmission microscope. All the EM
sections were reviewed in a blinded fashion. Pictures from each
kidney were acquired in a double blind manner using sample
numbers without the identity of the mouse.
Statistical analyses
Data were presented as means 6 standard deviation (SD) unless
otherwise noted. All experiments were repeated at least three times
with duplicate or triplicate samples in each assay. All data were
evaluated statistically by the analysis of variance (ANOVA),
followed by Nweman-Keuls multiple comparison tests using
software (Prism 4.0, GraphPad Software). In the case of single
mean comparison, data were analyzed by t test. P values ,0.05
were regarded as statistically significant.
Figure 2. Opiate receptors are expressed in mouse podocytes. Paraffin sections were prepared from 2-month-old mice kidneys, and
immunofluorescence staining was performed to detect the expression of opiate receptors. Nephrin was used as a marker of podocytes.
doi:10.1371/journal.pone.0055748.g002
Figure 3. Morphine administration leads to albuminuria. Two-
month old mice were administered with either normal saline or
morphine by subcutaneous implantation of a 75-mg slow-release
morphine pellet. After 72 h urine was collected, and the amount of
albumin (A) and albumin/creatinine ratio (B) were determined.
doi:10.1371/journal.pone.0055748.g003
Morphine and Podocyte Injury
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Figure 4. Morphine-receiving mice display alterations in SD molecules and effeacement of foot processes of podocytes. A. Two-
month-old mice were administrated either normal saline or morphine for 3 days. Frozen sections were prepared for immuno-fluorescence staining. B.
kidneys were homogenized, and the tissue lysates were subjected to Western blot to detect the changes of nephrin and synaptopodin. C–D.
Quantification of the expression of nephrin (C) and synaptopodin (D), and the results (mean 6 SD) represent three independent samples. E. A
representative microphotograph from transmission electron microscopy studies. Foot processes are indicated by arrows. Foot processes are well
delineated and are not fused in the control, while they are fused (effaced) in morphine-receiving mice. The scale bar is 500 nm. Mag. 270,000X.
doi:10.1371/journal.pone.0055748.g004
Figure 5. Morphine decreases podocyte expression of SD molecules. A. Differentiated human podocytes were treated with 1028 or 1026 M
morphine for 24 h, and the cell lysates were collected for Western blots. B–E. Quantification of the expression of nephrin (B), synaptopodin (C),
CD2AP (D), and podocin (E) in A, and the results (mean 6 SD) represent three independent samples. * p,0.05 compared with control (0 M).
doi:10.1371/journal.pone.0055748.g005
Morphine and Podocyte Injury
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Results
Classic opiate receptors are present on podocytes
Opiate receptors (ORs) have been reported to express in kidney
messangial cells [6], but their expression in podocytes has not been
studied. Therefore, we examined the expression of ORs in
podocytes. In in vitro study, we conducted RT-PCR analysis by
using human podocytes as the RNA source. The results revealed
high level expression of KOR and MOR in human podocytes, but
the expression of DOR was barely detectable (Fig. 1). To confirm
this observation in in vivo studies, we performed immunofluores-
cence staining of mouse kidney sections. Both KOR and MOR
were highly expressed in kidney, and they were colocalized with
podocyte marker nephrin; while no DOR expression was found in
podocyte (Fig. 2). These results demonstrate that podocytes display
expression of KOR and MOR only.
Morphine treatment leads to acute albuminuria
It has been reported that chronic morphine treatment leads to
glomerulophathy particularly proteinuria [5]. To examine the
effect of morphine on podocytes, we treated the mice with high
dose morphine as described in Materials and Methods. Three
days after the treatment, mouse urine samples were collected,
and total albumin and albumin/creatinine ratio were deter-
mined. The histology in Periodic acid-Schiff (PAS)-stained mouse
kidney sections was also examined. Although we didn’t find
obvious differences between the control and treatment groups in
the histology (data not shown), we did observe that high dose
morphine treatment significantly increased both total albumin
and albumin/creatinine ratio in the urine (Fig. 3). These results
suggest that morphine treatment directly impairs the blood urine
barrier.
Morphine treatment compromises podocyte integrity
To determine the effect of morphine on podocytes, we
performed immunofluorescent staining of mouse kidney sections
and immunoblotting studies of the kidney lysates. Morphine
attenuated the expression of podocyte specific molecules such as
synaptopodin and nephrin (Fig. 4, A–D). In vitro study also showed
that morphine treatments decreased the protein expression of
SDCMs in human podocytes (Fig. 5). Transmission electron
microscopy of the mouse kidney sections showed that morphine
administration increased the podocyte foot process effacement
(Figure 4E). These results indicate that morphine treatment may
compromise podocyte integrity.
Morphine mediates alterations in podocyte SDCMs via
MOR and KOR
Weber et al reported that morphine affects mesangial cells
mainly via KOR but not MOR [6]. To determine the receptors
involved in podocytes, we stimulated human podocytes with OR-
specific agonists. Western blot results revealed that both KOR-
specific agonist LKD26 and MOR-specific agonist DAMGO
decreased the expression of SDCMs, while DOR-specific agonist
DPDPE did not show this function (Fig. 6). These results indicate
that morphine-induced alterations in podocyte SDCM occurred
via both KOR and MOR.
Morphine induces podocyte DNA damage through ROS
generation
Our group and others have demonstrated that ROS is a
significant contributing factor for podocyte injury and for the
progression of chronic kidney disease [8,19,20]. ROS has also
been shown to damage SD [21,22,23]. To examine the effect of
morphine on intracellular ROS production, the fluorescence
intensity of the intracellular fluoroprobe (DCFH) was evaluated.
Results showed that ROS generation was significantly increased in
Figure 6. Morphine affects podocytes through K and M receptors. A. Human podocytes were treated with agonists specifically for DOR
(labeled as D), KOR (K), or MOR (M) for 24 h, and the cell lysates were collected for Western blots. B–E. Quantification of the expression of nephrin (B),
synaptopodin (C), CD2AP (D), and podocin (E) in A, and the results (mean 6 SD) represent three independent samples. * p,0.05 compared with
control (CN).
doi:10.1371/journal.pone.0055748.g006
Morphine and Podocyte Injury
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morphine-treated cells as compared with unstimulated cells
(Figure 7). Morphine increased ROS generation in a dose-
dependent manner (Figure 7A).
To determine the effect of morphine-induced ROS generation
on oxidative DNA damage in the podocyte, we carried out
immunofluorescent staining of podocytes for 8-hydroxyguanine (8-
OHdG), a molecular marker of oxidative damage to DNA, in
morphine-receiving mice. Morphine-receiving mice displayed
increased positive staining of 8-OHdG in podocytes (Figure 7C).
To test the effect of oxidative stress on SDCMs, aliquots of
variable concentrations of hydrogen peroxide (H2O2) were added
to the media of human podocytes for 24 h. Western blotting
studies revealed that H2O2 decreased SDCMs expression in a
dose-dependent manner (Figure 8). To further confirm these
observations, podocytes were pre-treated with either superoxide
dismutase or catalase and then incubated in media containing
H2O2. As shown in Figure 9, pretreating the human podocytes
with SOD or catalase significantly attenuated morphine-induced
compromise of SDCMs. Taken together, these data suggest that
morphine-induced ROS generation may be a contributor to the
decrease of SDCMs.
AKT, JNK, and p38 pathways are involved in opioid-
induced podocyte injury
Several kinases, including AKT, JNK, Erk1/2 and p38 have
been implicated in podocyte injury and the progression of chronic
kidney diseases (CKD) [6,15,24,25,26]. A transcription factor,
signal transducer and activator of transcription 3 (STAT3), has
also been reported to regulate HIV-induced podocyte proliferation
[24]. To examine the involvement of these kinases and factors in
morphine-induced down-regulation of SDCMs, we first evaluated
the phosphorylation of these proteins. We treated the human
podocytes with morphine, and collected the cell lysates at different
time points for Western blot studies. Results showed that
morphine stimulation significantly activated AKT, JNK, and
p38 at early time points (Fig. 10), while neither Erk1/2 nor
STAT3 could be activated by morphine at any time point (data
not shown). We also used KOR- and MOR-specific agonists,
LKD26 and DAMGO, to stimulate the human podocytes, and the
same activation results with morphine were observed (data not
shown). These results suggest that morphine down-regulates
SDCMs via AKT, JNK, and p38, but not Erk1/2 or STAT3.
To further examine the role of activation of AKT, JNK, and
p38 in morphine-induced down-regulation of SDCMs, the
expression of SDCMs was measured in podocytes treated with
morphine in the presence or absence of LY294002, an inhibitor of
PI13/AKT, SP600125, an inhibitor of JNK, or SB203580, an
Figure 7. Morphine increases ROS generation in podocyte. A. Human podocytes were treated with 10210 to 1026 M morphine for 12 h, and
were labeled with DCFH for 30 min. After washing with PBS, the cells were incubated at room temperature for 2 h, and the ROS generation was
determined. * p,0.001 compared with control (0 M). B. Kinetics of ROS generation for 1026 M morphine treatment. C. Paraffin sections were
prepared from control or morphine-receiving mice, and immunofluorescent staining was performed to detect the nuclear expression of 8-OHdG, a
molecular marker of oxidative damage to DNA. WT1 was used as a marker of podocytes.
doi:10.1371/journal.pone.0055748.g007
Morphine and Podocyte Injury
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Figure 8. H2O2 decreases podocyte expression of SD molecules. A. Human podocytes were treated with 1, 10, or 50 mM H2O2 for 24 h, and
the cell lysates were collected for Western blots. B–E. Quantification of the expression of nephrin (B), synaptopodin (C), CD2AP (D), and podocin (E)
in A, and the results (mean 6 SD) represent three independent samples. * p,0.05, ** p,0.01 compared with control (0 mM).
doi:10.1371/journal.pone.0055748.g008
Figure 9. SOD and catalase attenuate morphine-induced decrease of podcoyte expression of SD molecules. A. Human podocytes were
pretreated with SOD or catalase for 1 h before 1026 M morphine was added. After another 24 h incubation at 37uC, the cell lysates were collected for
Western blot. B–E. Quantification of the expression of nephrin (B), synaptopodin (C), CD2AP (D), and podocin (E) in A, and the results (mean 6 SD)
represent three independent samples. * p,0.05 compared with blank control, while # p,0.05 compared with morphine treatment alone.
doi:10.1371/journal.pone.0055748.g009
Morphine and Podocyte Injury
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inhibitor of p38. As presented in Figure 11, all these inhibitors
partially attenuated morphine-induced down-regulation of
SDCMs. These results indicate that AKT, JNK, and p38
pathways are involved in the regulation of morphine-induced
impairment of SDCMs.
Discussion
Morphine has been reported to cause kidney cell injury in both
in vitro and in vivo studies [7,8,9,10,11,12]. In the current study, we
observed that administration of morphine contributed to albu-
minuria which appeared to be glomerular in origin and a
consequence of the loss of slit diaphragm integrity [27]. Both in
vivo and in vitro data confirmed that morphine inflicted podocyte
injury in the form of attenuated expression of SDCMs (Figure 4
and 5); these findings further confirmed that loss of integrity of SD
contributed to albuminuria in morphine-receiving mice. Since
these SDCMs are actin-associated molecules, the reduced level of
expression of these molecules by morphine may change the actin
cytoskeleton organization. Transmission electron microscopy of
the mouse kidney sections showed effacement of podocyte foot
process in morphine-receiving mice (Figure 4E), which might be
due to the change of the actin cytoskeleton organization. However,
further studies are needed to explore this aspect.
In previously reported studies, morphine has been demonstrat-
ed to exert bimodal effects (both apoptosis and proliferation) on
glomerular epithelial cells [8]; however the role of opiate receptors
was not evaluated in these studies. In the current study, we found
that KOR and MOR, but not DOR, were expressed in both
human and mouse podocytes (Figures 1 and 2). We also found that
stimulating either KOR or MOR in podocytes could activate
related kinases and down-regulate SDCMs. To our knowledge,
this is the first report on the opiate receptors in podocytes. Weber
Figure 10. Morphine activates AKT, p38 and JNK. Human
podocytes were starved in serum free medium for 12 h, and then
1026 M morphine was added. Cell lysates were collected at different
time points for Western blot.
doi:10.1371/journal.pone.0055748.g010
Figure 11. Inhibition of AKT, p38, and JNK attenuates morphine-induced decrease of SD molecules expression. A. Human podocytes
were pretreated with of LY294002 (LY), SB203580 (SB), or SP600125 (SP) for 1 h before 1026 M morphine was added. After another 24 h incubation at
37uC, the cell lysate were collected for Western blot. B–E. Quantification of the expression of nephrin (B), synaptopodin (C), CD2AP (D), and podocin
(E) in A, and the results (mean 6 SD) represent three independent samples. * p,0.05 compared with blank control, while # p,0.05 compared with
morphine treatment alone.
doi:10.1371/journal.pone.0055748.g011
Morphine and Podocyte Injury
PLOS ONE | www.plosone.org 8 March 2013 | Volume 8 | Issue 3 | e55748
et al reported that although both KOR and MOR were expressed
in glomerular mesangial cells, only KOR played the function to
activate STAT3 and led to the proliferation and glomerulopathy
[6]. These findings indicate that podocytes behave differently from
mesangial cells in morphine milieu.
Oxidative stress is a common cause of cellular injury. Several
investigators have demonstrated that enhanced ROS generation
leads to albuminuria by damaging SD components [21,28,29].
Morphine has been demonstrated to stimulate the production of
superoxide by macrophage and mesangial cells [22,23]. As we
previously reported, generation of ROS induces apoptosis of rat
glomerular epithelial cells [8]. Here we also found that morphine
increased ROS generation in human podocytes in a dose-
dependent manner (Figure 7A). Addition of H2O2 to the media
decreased the expression of SDCMs (Figure 8), while free radical
scavengers prevented this damaging effect of morphine (Figure 9).
All these findings strongly suggest the role of ROS in morphine-
induced down-regulation of SDCMs. One potential possibility is
that ROS induced injury hampers the expression of SDCMs.
Further investigation into the detailed underlying mechanisms
need to be carried out in future studies.
Investigating the kinase or transcription factor pathways
involved in morphine-induced kidney injury may provide insight
into new potential targets for therapy. STAT3, AKT and mitogen-
activated protein (MAP) kinases, including ERK1/2, JNK, and
p38, have been implicated in podocyte injury and the progression
of chronic kidney diseases (CKD) [6,14,24,25,26]. All these kinases
or transcription factors may also be activated by morphine in
various cells [6,30,31]. We examined the effect of morphine on the
activation of these kinases and factors in podocytes. Our results
revealed that morphine stimulated the phosphorylation of AKT,
JNK and p38 (Figure 10), but could not activate Erk1/2 or
STAT3 (data not shown). These observations were further
confirmed by the use of KOR and MOR specific agonists on
human podocytes in morphine milieu (data not shown).
Takano et al reported that activation of AKT suppressed the
expression of nephrin [32]; Ikezumi et al claimed that activation of
JNK or p38 decreased the expression of nephrin and podocin,
while inhibiting these kinases restored their expressions [33].
Consistent with these reports, we also found that inhibiting AKT,
JNK, and p38 could partially prevent the morphine-induced
decrease of SDCMs (Figure 11), indicating the regulation of these
three kinases in morphine-induced SD damage.
In conclusion, we have demonstrated that morphine has the
potential to directly impair the SDCMs in podocytes, which will
contribute to acute kidney injury. The effects of morphine on
podocytes are mediated through both MOR and KOR. These
impairments are through generation of ROS, and are regulated by
AKT, JNK, and p38 pathways. Our study provides insight into
new mechanisms involved in morphine-induced podocyte damage,
and highlights some new therapeutic targets for morphine induced
kidney injury.
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